Effects and Mechanisms of H3K27ac Regulated NORAD-PUM1/2 on Atherosclerotic Inflammation

Effects and Mechanisms of H3K27ac Regulated NORAD on Atherosclerotic Inflammation via PUM1/2

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000029472

Enrollment

Unknown

Registered

2020-02-02

Start date

2020-06-01

Completion date

Unknown

Last updated

2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis

Interventions

Stable plaques:No intervention

Unstable:No intervention

Sponsors

Changsha Medical College

Lead Sponsor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Asymptomatic narrow >70%, or symptomatic stenosis >50% ;

Exclusion criteria

Exclusion criteria: Ehlers-Danlos syndrome, bicuspid aortic valves, Marfan syndrome, connective tissue disease.

Design outcomes

Primary

Measure	Time frame
gene expression level;	—

Countries

China

Contacts

Public ContactBao Meihua

Changsha Medical College

mhbao78@163.com+86 15388026775

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026